Madaus is new CEO at Carlyle's Ortho-Clinical Diagnostics

Carlyle Group, the new private equity owner of Ortho-Clinical Diagnostics, the former Johnson & Johnson blood testing unit, named Martin Madaus as CEO.

The Carlyle Group said it tapped Martin Madaus to take over as CEO of the Ortho-Clinical Diagnostics business it's acquiring from Johnson & Johnson (NYSE:JNJ).

Carlyle Group, Johnson & Johnson, Merck KGaA, Millipore Corp., Ortho-Clinical Diagnostics, Roche

News Well, Diagnostics, Personnel

read more

from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1eBBLfo